Works matching IS 15228517 AND DT 2008 AND VI 10 AND IP 3
1
- Neuro-Oncology, 2008, v. 10, n. 3, p. 489
- Article
2
- Neuro-Oncology, 2008, v. 10, n. 3, p. 476
- Article
3
- Neuro-Oncology, 2008, v. 10, n. 3, p. 538
- Article
4
- Neuro-Oncology, 2008, v. 10, n. 3, p. 506
- Article
5
- Neuro-Oncology, 2008, v. 10, n. 3, p. 500
- Article
6
- Neuro-Oncology, 2008, v. 10, n. 3, p. 496
- Article
7
- Neuro-Oncology, 2008, v. 10, n. 3, p. 474
- Article
8
- Neuro-Oncology, 2008, v. 10, n. 3, p. 470
- Article
9
- Neuro-Oncology, 2008, v. 10, n. 3, p. 464
- Article
10
- Neuro-Oncology, 2008, v. 10, n. 3, p. 461
- Article
11
- Neuro-Oncology, 2008, v. 10, n. 3, p. 454
- Article
12
- Neuro-Oncology, 2008, v. 10, n. 3, p. 446
- Article
13
- Neuro-Oncology, 2008, v. 10, n. 3, p. 443
- Article
14
- Neuro-Oncology, 2008, v. 10, n. 3, p. 438
- Article
15
- Neuro-Oncology, 2008, v. 10, n. 3, p. 433
- Article
16
- Neuro-Oncology, 2008, v. 10, n. 3, p. 428
- Article
17
- Neuro-Oncology, 2008, v. 10, n. 3, p. 424
- Article
18
- Neuro-Oncology, 2008, v. 10, n. 3, p. 421
- Article
19
- Neuro-Oncology, 2008, v. 10, n. 3, p. 417
- Article
20
- Neuro-Oncology, 2008, v. 10, n. 3, p. 410
- Article
21
- Neuro-Oncology, 2008, v. 10, n. 3, p. 406
- Article
22
- Neuro-Oncology, 2008, v. 10, n. 3, p. 402
- Article
23
- Neuro-Oncology, 2008, v. 10, n. 3, p. 396
- Article
24
- Neuro-Oncology, 2008, v. 10, n. 3, p. 244, doi. 10.1215/15228517-2008-016
- Article
25
- Neuro-Oncology, 2008, v. 10, n. 3, p. 395
- Article
26
- Neuro-Oncology, 2008, v. 10, n. 3, p. 374
- Article
27
- Neuro-Oncology, 2008, v. 10, n. 3, p. 361, doi. 10.1215/15228517-2008-008
- Article
28
- Neuro-Oncology, 2008, v. 10, n. 3, p. 370
- Article
29
- Neuro-Oncology, 2008, v. 10, n. 3, p. 391
- Article
30
- Neuro-Oncology, 2008, v. 10, n. 3, p. 355, doi. 10.1215/15228517-2008-009
- Article
31
- Neuro-Oncology, 2008, v. 10, n. 3, p. 341, doi. 10.1215/15228517-2008-004
- Article
32
- Neuro-Oncology, 2008, v. 10, n. 3, p. 348, doi. 10.1215/15228517-2008-007
- Article
33
- Neuro-Oncology, 2008, v. 10, n. 3, p. 330, doi. 10.1215/15228517-2008-003
- Article
34
- Neuro-Oncology, 2008, v. 10, n. 3, p. 309, doi. 10.1215/15228517-2007-063
- Article
35
- Neuro-Oncology, 2008, v. 10, n. 3, p. 320, doi. 10.1215/15228517-2008-012
- Article
36
- Neuro-Oncology, 2008, v. 10, n. 3, p. 292, doi. 10.1215/15228517-2008-014
- Article
37
- Neuro-Oncology, 2008, v. 10, n. 3, p. 265, doi. 10.1215/15228517-2007-066
- Article
38
- Neuro-Oncology, 2008, v. 10, n. 3, p. 300, doi. 10.1215/15228517-2008-005
- Article
39
- Neuro-Oncology, 2008, v. 10, n. 3, p. 275, doi. 10.1215/15228517-2008-015
- Article
40
- Neuro-Oncology, 2008, v. 10, n. 3, p. 254, doi. 10.1215/15228517-2008-001
- Article
41
- Neuro-Oncology, 2008, v. 10, n. 3, p. 236, doi. 10.1215/15228517-2008-006
- Article
42
- Neuro-Oncology, 2008, v. 10, n. 3, p. 235, doi. 10.1215/15228517-2008-023
- Article